Hospitalisation for venous thromboembolism in cancer patients and the general population: A population-based cohort study in Denmark, 1997-2006

British Journal of Cancer

Volumn 103, Issue 7, 2010, Pages 947-953

  Cronin Fenton, D P ^a   Sondergaard F ^a   Pedersen, L A ^a   Fryzek, J P ^b   Cetin, K ^b   Acquavella, J ^b   Baron, J A ^c   Sorensen H T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Department of Epidemiology ^*  (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

epidemiology; incidence rate; treatment; venous thromboembolism

Indexed keywords

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER THERAPY; COMORBIDITY; DENMARK; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INCIDENCE; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PALLIATIVE THERAPY; PANCREAS TUMOR; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM; COHORT ANALYSIS; COMPLICATION; HEALTH SURVEY; MIDDLE AGED; NEOPLASM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; DENMARK; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POPULATION SURVEILLANCE; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

EID: 77957220636     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605883     Document Type: Article

References (40)

1. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH (1999) The danish national hospital register. A valuable source of data for modern health sciences. Dan Med Bull 46(3): 263-268
2. Arcelus JI, Caprini JA, Monreal M, Suarez C, Gonzalez-Fajardo J (2003) The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients. J Vasc Surg 38(5): 916-922 (Pubitemid 37409622)
3. Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M (1998) Venous thromboembolism and cancer. Lancet 351(9109): 1077-1080 (Pubitemid 28163410)
4. Bernardi E, Piccioli A, Marchiori A, Girolami B, Prandoni P (2001) Upper extremity deep vein thrombosis: risk factors, diagnosis, and management. Semin Vasc Med 1(1): 105-110
5. Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293(6): 715-722 (Pubitemid 40216041)
6. Blom JW, Osanto S, Rosendaal FR (2006a) High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients. Eur J Cancer 42(3): 410-414 (Pubitemid 43132898)
7. Blom JW, Vanderschoot JP, Oostindier MJ, Osanto S, van der Meer FJ, Rosendaal FR (2006b) Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 4(3): 529-535
8. Chew HK, Wun T, Harvey D, Zhou H, White RH (2006) Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166(4): 458-464 (Pubitemid 43313651)
9. Falanga A, Marchetti M (2009) Venous thromboembolism in the hematologic malignancies. J Clin Oncol 27(29): 4848-4857
10. Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287(5462): 2398-2399
11. Glynn RJ, Rosner B (2005) Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 162(10): 975-982 (Pubitemid 41619468)
12. Gouin-Thibault I, Achkar A, Samama MM (2001) The thrombophilic state in cancer patients. Acta Haematol 106(1-2): 33-42 (Pubitemid 32830514)
13. Hales BF (1999) Thalidomide on the comeback trail. Nat Med 5(5): 489-490
14. Heit JA, Melton III LJ, Lohse CM, Petterson TM, Silverstein MD, Mohr DN, OFallon WM (2001) Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc 76(11): 1102-1110
15. Hernandez RK, Sorensen HT, Pedersen L, Jacobsen J, Lash TL (2009) Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study. Cancer
16. Huerta C, Johansson S, Wallander MA, Garcia Rodriguez LA (2007) Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 167(9): 935-943 (Pubitemid 46762756)
17. Kakkar AK (2010) Cancer-associated thrombosis. Br J Cancer 102(Suppl 1): S1
18. Keenan CR, White RH (2007) The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med 13(5): 377-383 (Pubitemid 47472297)
19. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 110(10): 2339-2346 (Pubitemid 350100757)
20. Knight R, DeLap RJ, Zeldis JB (2006) Lenalidomide and venous thrombosis in multiple myeloma. N Engl J Med 354(19): 2079-2080
21. Lensing AW, Prandoni P, Brandjes D, Huisman PM, Vigo M, Tomasella G, Krekt J, Wouter Ten Cate J, Huisman MV, Buller HR (1989) Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 320(6): 342-345 (Pubitemid 19106869)
22. Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, Rimm AA (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 78(5): 285-291 (Pubitemid 29439263)
23. Ludbrook J, Royse AG (2008) Analysing clinical studies: principles, practice and pitfalls of Kaplan-Meier plots. ANZ J Surg 78(3): 204-210 (Pubitemid 351207401)
24. Ogren M, Bergqvist D, Wahlander K, Eriksson H, Sternby NH (2006) Trousseaus syndrome-what is the evidence? A population-based autopsy study. Thromb Haemost 95(3): 541-545
25. Otten HM, Mathijssen J, ten Cate H, Soesan M, Inghels M, Richel DJ, Prins MH (2004) Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med 164(2): 190-194 (Pubitemid 38140406)
26. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB (2006) The danish civil registration system. A cohort of eight million persons. Dan Med Bull 53(4): 441-449 (Pubitemid 44816920)
27. Prandoni P, Falanga A, Piccioli A (2005) Cancer and venous thromboembolism. Lancet Oncol 6(6): 401-410 (Pubitemid 40753746)
28. Rickles FR, Levine MN (2001) Epidemiology of thrombosis in cancer. Acta Haematol 106(1-2): 6-12
29. Rodriguez AO, Wun T, Chew H, Zhou H, Harvey D, White RH (2007) Venous thromboembolism in ovarian cancer. Gynecol Oncol 105(3): 784-790 (Pubitemid 46734211)
30. Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tjonneland A, Johnsen SP (2010) Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol 63(2): 223-228
31. Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B (1999) Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 341(21): 1565-1571
32. Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL (1998) The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 338(17): 1169-1173 (Pubitemid 28180744)
33. Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE (2006) Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 119(1): 60-68 (Pubitemid 43117468)
34. Storm HH (1988) Completeness of cancer registration in Denmark 1943- 1966 and efficacy of record linkage procedures. Int J Epidemiol 17(1): 44-49
35. Storm HH, Michelsen EV, Clemmensen IH, Pihl J (1997) The danish cancer registry-history, content, quality and use. Dan Med Bull 44(5): 535-539 (Pubitemid 27505373)
36. Sundhedsstyrelsen (1986) Klassifikation af sygdomme, 8 revision Sundhedsstyrelsen: Copenhagen
37. Sundhedsstyrelsen (1993) Klassifikation af sygdomme, 10 revision Copenhagen
38. Trousseau A (1865) Phlegmasia alba dolens. In Clinique Medicale de lHotel-Dieu de Paris, Bailliere J (ed) 2nd edn, pp 654-712. JB Bailliere & Fils: Paris, France
39. White RH, Chew H, Wun T (2007) Targeting patients for anticoagulant prophylaxis trials in patients with cancer: Who is at highest risk? Thromb Res 120(Suppl 2): S29-S40 (Pubitemid 350101771)
40. Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, Furie B (2009) Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 15(22): 6830-6840